2,000-Centigray total lymphoid irradiation for refractory rheumatoid arthritis
β Scribed by David E. Trentham; James A. Belli; William D. Bloomer; Ronald J. Anderson; Heather Lane; Ellis L. Reinherz; K. Frank Austen
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 731 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Because toxicity with the use of 3,000 centiGray (cGy ) of total lymphoid irradiation (TLI) was observed in an earlier study, 2,000-cGy treatments were delivered in a 2-portal format to 7 patients and in a modified 3portal fashion to 6 patients, as part of a randomized, investigator-blinded trial of TLI treatment for refractory rheumatoid arthritis. Analysis of combined data from the 13 patients revealed statistically significant improvement in 5 clinical indicators of disease activity at the end of TLI and 6 and 12 months later, accompanied by T4specific immunosuppression. Management considerations resulted in the introduction of prednisone therapy in 5 patients, methotrexate in 4, and azathio-_____ From the Departments of Medicine and Radiation Therapy,
π SIMILAR VOLUMES
Total lymphoid irradiation (TLI) was administered to 11 patients who had intractable rheumatoid arthritis that was unresponsive to conventional medical therapy, including aspirin, multiple nonsteroidal antiinflammatory drugs, gold salts, and D-penicillamine. Total lymphoid irradiation was given as a